Ken Mariash

Ken Mariash has a diverse and extensive work experience. Ken is currently the CEO of Sinaptica Therapeutics, a company developing closed-loop neuromodulation therapy for Alzheimer's. Prior to this, Ken was the Founder & Managing Partner of Rubicon Strategy Partners, LLC, where they helped leadership make important investment decisions. Ken also worked as the Vice President of Marketing at EBT Medical, Inc., overseeing all commercial aspects of the company's neurostimulator and companion app. Ken gained significant experience at Boston Scientific Neuromodulation, where they served as the Director of Strategy and New Markets, and was involved in various acquisitions and strategic planning. Previously, they held leadership roles at Baxter BioScience, CSL Behring, Charles River Associates, and Harvard Business School.

Ken Mariash attended Brown University, where they studied Biochemistry and Business Economics, focusing on the field of Business/Managerial Economics. The start and end years of their education are not specified.